SYRS - Syros Pharmaceuticals (SYRS) CEO Nancy Simonian on Q1 2021 Results - Earnings Call Transcript
Syros Pharmaceuticals, Inc. (SYRS) Q1 2021 Earnings Conference Call May 06, 2021, 08:30 AM ET Company Participants Naomi Aoki - VP, CC&IR Nancy Simonian - CEO David Roth - CMO Joe Ferra - CFO Eric Olson - CSO Conference Call Participants Phil Nadeau - Cowen & Company Jason Butler - JMP Securities Mark Breidenbach - Oppenheimer Zegbeh Jallah - ROTH Capital Partners Ted Tenthoff - Piper Sandler Presentation Operator Good morning. And welcome to Syros Pharmaceuticals First Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. This call is being webcast live on the Investors & Media section of Syros' website at www.syros.com. Please be advised that today's call is being recorded. Following the formal remarks, we will open up the call up for your questions. At this time, I would like to turn the call over to Naomi Aoki, Vice President of
For further details see:
Syros Pharmaceuticals (SYRS) CEO Nancy Simonian on Q1 2021 Results - Earnings Call Transcript